These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 16757203)

  • 21. Cyclophosphamide, doxorubicin, and cisplatin in advanced salivary gland cancer.
    Debaere D; Vander Poorten V; Nuyts S; Hauben E; Schoenaers J; Schöffski P; Clement PM
    B-ENT; 2011; 7(1):1-6. PubMed ID: 21563549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imatinib mesylate can induce objective response in progressing, highly expressing KIT adenoid cystic carcinoma of the salivary glands.
    Faivre S; Raymond E; Casiraghi O; Temam S; Berthaud P
    J Clin Oncol; 2005 Sep; 23(25):6271-3; author reply 6273-4. PubMed ID: 16135502
    [No Abstract]   [Full Text] [Related]  

  • 23. Adding concurrent chemotherapy to postoperative radiotherapy improves locoregional control but Not overall survival in patients with salivary gland adenoid cystic carcinoma-a propensity score matched study.
    Hsieh CE; Lin CY; Lee LY; Yang LY; Wang CC; Wang HM; Chang JT; Fan KH; Liao CT; Yen TC; Fang KH; Tsang YM
    Radiat Oncol; 2016 Mar; 11():47. PubMed ID: 27000157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review.
    Laurie SA; Ho AL; Fury MG; Sherman E; Pfister DG
    Lancet Oncol; 2011 Aug; 12(8):815-24. PubMed ID: 21147032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study.
    Locati LD; Bossi P; Perrone F; Potepan P; Crippa F; Mariani L; Casieri P; Orsenigo M; Losa M; Bergamini C; Liberatoscioli C; Quattrone P; Calderone RG; Rinaldi G; Pilotti S; Licitra L
    Oral Oncol; 2009 Jul; 45(7):574-8. PubMed ID: 18804410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Response to metronomic chemotherapy in a metastatic adenoid cystic carcinoma of the parotid gland].
    Visa L; Caballero M; Grau JJ
    Acta Otorrinolaringol Esp; 2010; 61(6):452-4. PubMed ID: 20152955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential KIT expression in histological subtypes of adenoid cystic carcinoma (ACC) of the salivary gland.
    Freier K; Flechtenmacher C; Walch A; Devens F; Mühling J; Lichter P; Joos S; Hofele C
    Oral Oncol; 2005 Oct; 41(9):934-9. PubMed ID: 16054424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors.
    Wong SJ; Karrison T; Hayes DN; Kies MS; Cullen KJ; Tanvetyanon T; Argiris A; Takebe N; Lim D; Saba NF; Worden FP; Gilbert J; Lenz HJ; Razak AR; Roberts JD; Vokes EE; Cohen EE
    Ann Oncol; 2016 Feb; 27(2):318-23. PubMed ID: 26598548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [An antimetastatic study of Arg-Asp (RD) on salivary adenoid cystic carcinoma in vivo].
    Li F; Yu G; Li S; Peng S; Fu J; Wu D
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Mar; 37(2):87-9. PubMed ID: 12475414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphologic diversity of malignant neoplasms arising in preexisting spiradenoma, cylindroma, and spiradenocylindroma based on the study of 24 cases, sporadic or occurring in the setting of Brooke-Spiegler syndrome.
    Kazakov DV; Zelger B; Rütten A; Vazmitel M; Spagnolo DV; Kacerovska D; Vanecek T; Grossmann P; Sima R; Grayson W; Calonje E; Koren J; Mukensnabl P; Danis D; Michal M
    Am J Surg Pathol; 2009 May; 33(5):705-19. PubMed ID: 19194280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic therapy in the management of metastatic or advanced salivary gland cancers.
    Lagha A; Chraiet N; Ayadi M; Krimi S; Allani B; Rifi H; Raies H; Mezlini A
    Oral Oncol; 2012 Oct; 48(10):948-957. PubMed ID: 22698431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy for salivary gland cancer.
    Kaplan MJ; Johns ME; Cantrell RW
    Otolaryngol Head Neck Surg; 1986 Sep; 95(2):165-70. PubMed ID: 3035459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of autophagy enhances cisplatin cytotoxicity in human adenoid cystic carcinoma cells of salivary glands.
    Ma B; Liang LZ; Liao GQ; Liang YJ; Liu HC; Zheng GS; Su YX
    J Oral Pathol Med; 2013 Nov; 42(10):774-80. PubMed ID: 23590333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antimetastatic effects of genistein on salivary adenoid cystic carcinoma in vivo].
    Liu H; Yu GY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Sep; 39(5):373-5. PubMed ID: 15498340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and toxicity of sorafenib in patients with adenoid cystic carcinoma of the head and neck: a case series of five patients.
    Couvreur K; Celine J; Marlies B; Randal D; Philippe D; Frederic D; Sylvie R
    Acta Clin Belg; 2020 Oct; 75(5):362-369. PubMed ID: 31232197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II trial of taxol in salivary gland malignancies (E1394): a trial of the Eastern Cooperative Oncology Group.
    Gilbert J; Li Y; Pinto HA; Jennings T; Kies MS; Silverman P; Forastiere AA
    Head Neck; 2006 Mar; 28(3):197-204. PubMed ID: 16470745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands.
    Agulnik M; Cohen EW; Cohen RB; Chen EX; Vokes EE; Hotte SJ; Winquist E; Laurie S; Hayes DN; Dancey JE; Brown S; Pond GR; Lorimer I; Daneshmand M; Ho J; Tsao MS; Siu LL
    J Clin Oncol; 2007 Sep; 25(25):3978-84. PubMed ID: 17761983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenoid cystic carcinoma with high-grade transformation: a report of 11 cases and a review of the literature.
    Seethala RR; Hunt JL; Baloch ZW; Livolsi VA; Leon Barnes E
    Am J Surg Pathol; 2007 Nov; 31(11):1683-94. PubMed ID: 18059225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II study of gefitinib in patients with advanced salivary gland cancers.
    Jakob JA; Kies MS; Glisson BS; Kupferman ME; Liu DD; Lee JJ; El-Naggar AK; Gonzalez-Angulo AM; Blumenschein GR
    Head Neck; 2015 May; 37(5):644-9. PubMed ID: 24585506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promoter methylation as a common mechanism for inactivating E-cadherin in human salivary gland adenoid cystic carcinoma.
    Zhang CY; Mao L; Li L; Tian Z; Zhou XJ; Zhang ZY; Li J
    Cancer; 2007 Jul; 110(1):87-95. PubMed ID: 17520682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.